alphaveNATCOPHARM₹818.80

NATCO Pharma Ltd.

₹ CrorePeersDRREDDY ZYDUSLIFE SUNPHARMA LALPATHLAB NEULANDLAB NH SAILIFE COHANCEMcap ₹14,657 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	2,297.7	2,431.9	2,545.4	2,545.4
+ Capital Work-in-Progress	137.3	225.4	293.7	293.7
+ Goodwill	56.0	57.4	63.0	63.0
+ Other Intangibles	137.1	208.7	194.3	194.3
+ Investments (Equity Method)	—	—	2,275.7	2,275.7
+ Non-current Investments	95.9	152.8	273.2	273.2
+ Other Non-current Financial Assets	43.9	182.3	62.0	62.0
Non-current Financial Assets	139.8	335.1	335.2	335.2
+ Deferred Tax Assets	19.4	50.1	232.6	232.6
+ Other Non-current Assets	95.5	52.2	81.5	81.5
Total Non-current Assets	2,882.8	3,360.8	6,021.4	6,021.4
Current Assets
+ Inventories	700.5	765.8	908.5	908.5
+ Current Investments	443.5	320.8	578.2	578.2
+ Trade Receivables	1,188.9	1,246.6	881.2	881.2
+ Cash & Cash Equivalents	70.4	120.0	198.9	198.9
+ Other Bank Balances	882.5	2,056.0	1,352.0	1,352.0
+ Short-term Loans	9.0	9.4	9.8	9.8
+ Other Current Financial Assets	452.8	420.5	741.8	741.8
Current Financial Assets	3,047.1	4,173.3	3,761.9	3,761.9
+ Other Current Assets	275.9	330.9	381.9	381.9
Total Current Assets	4,023.5	5,270.0	5,052.3	5,052.3
Total Assets	6,906.3	8,630.8	11,073.7	11,073.7
Equity
+ Equity Share Capital	35.8	35.8	35.8	35.8
+ Other Equity / Reserves	5,817.3	7,571.2	9,185.3	9,185.3
Equity — Owners of Parent	5,853.1	7,607.0	9,221.1	9,221.1
+ Minority Interest	—	5.3	0.0	0.0
Total Equity	5,853.1	7,612.3	9,221.1	9,221.1
Liabilities
+ Borrowings — Non-current	0.0	0.0	100.0	100.0
+ Other Non-current Financial Liab	9.3	9.2	9.7	9.7
Non-current Financial Liabilities	9.3	9.2	109.7	109.7
+ Provisions — Non-current	70.9	65.6	61.8	61.8
+ Deferred Tax Liabilities	0.2	0.2	0.2	0.2
Non-current Liabilities	80.4	75.0	171.7	171.7
+ Borrowings — Current	363.2	273.1	606.4	606.4
+ Trade Payables	235.5	274.9	409.3	409.3
+ Other Current Financial Liab	104.8	116.3	141.4	141.4
Current Financial Liabilities	703.5	664.3	1,157.1	1,157.1
+ Provisions — Current	102.9	77.9	350.2	350.2
+ Current Tax Liabilities	32.3	79.0	0.5	0.5
+ Other Current Liabilities	134.1	122.3	173.1	173.1
Current Liabilities	972.8	943.5	1,680.9	1,680.9
Total Liabilities	1,053.2	1,018.5	1,852.6	1,852.6
Total Equity & Liabilities	6,906.3	8,630.8	11,073.7	11,073.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	17.6	27.8	27.8
+ Dues to Other Creditors — Current	—	257.3	381.5	381.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.